Lv11
28 积分 2023-07-11 加入
Anlotinib enhanced CD8+ T cell infiltration via induction of CCL5 improves the efficacy of PD-1/PD-L1 blockade therapy in lung cancer
1小时前
待确认
Lurbinectedin Plus Pembrolizumab in Relapsed SCLC: The Phase I/II LUPER Study
4小时前
已完结
Unraveling tumor microenvironment of small-cell lung cancer: Implications for immunotherapy
20天前
已完结
Current landscape of cross-line immune checkpoint blockade for cancer treatment
21天前
已完结
Evolving role of immunotherapy in small cell lung cancer
24天前
已完结
Second-line treatment strategies and clinical outcomes after progression on chemoimmunotherapy in extensive-stage small-cell lung cancer
24天前
已完结
Understanding tumour endothelial cell heterogeneity and function from single-cell omics
2个月前
已完结
Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance
2个月前
已完结
Small cell lung cancer with liver metastases: from underlying mechanisms to treatment strategies
2个月前
已完结
Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: a population-based study
2个月前
已完结
皖公网安备34019202002308
